Is this you? Create Your Porfile
Avatar

Tanaka Hirotaka

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Tanaka Hirotaka is active.

Explore More

Publication

Featured researches published by Tanaka Hirotaka.

Archive | 2012

DERIVADOS AMIDICOS COMO LIGANDOS DE CANALES IONICOS Y COMPOSICIONES FARMACEUTICAS Y METODOS DE USO DE LOS MISMOS.

Cox Matthew; O'mahony Donogh John; Estiarte-Marinez Maria De Los Angeles; Kawashima Tadashi; Nagayama Satoshi; Shisido Yuji; Tanaka Hirotaka; Duncton Matthew; Calabrese Andrew

Archive | 2011

AMIDDERIVATE ALS IONENKANALLIGANDEN SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGSVERFAHREN DAFÜR

Cox Matthew; O'mahony Donogh John; Estiarte-Marinez Maria; Kawashima Tadashi; Nagayama Satoshi; Shisido Yuji; Tanaka Hirotaka; Duncton Matthew; Calabrese Andrew

Archive | 2010

COMPUESTOS DE PIRIDILMETILBICICLOCARBOXAMIDA SUSTITUIDA

Tanaka Hirotaka; Nagayama Satoshi; Shishido Yuji

Archive | 2009

derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Archive | 2009

Substituierte n-sulfonylaminophenylethyl-2-phenoxyacetamidverbindungen

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nahayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Archive | 2008

DERIVES DE N-(N-SULFONYLAMINOMETHYL) CYCLOPROPANECARBOXAMIDE UTILES POUR LE TRAITEMENT DE LA DOULEUR

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Archive | 2007

N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Archive | 2007

Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Archive | 2006

NUEVOS COMPUESTOS DE N-(N-SULFONILAMINOARILMETIL) CICLOPROPANOCARBOXANIDA SUSTITUIDOS, COMOPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN A APLICACIONES.

Hanazawa Takeshi; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Hirano Misato; Shishido Yuji; Tanaka Hirotaka

Archive | 2006

DERIVADOS DE N-(N-SULFONILAMINOARILMETIL)CICLOPROPANOCARBOXAMIDA SUSTITUIDOS COMO ANTAGONISTAS DEL RECEPTOR VAINILLOIDE TIPO 1 (VDR1)

Hanazawa Takeshi; Hirano Misato; Inoue Tadashi; Nagayama Satoshi; Nakao Kazunari; Shishido Yuji; Tanaka Hirotaka

Explore More

Collaboration

Dive into the Tanaka Hirotaka's collaboration.

Top Co-Authors
Avatar

Hanazawa Takeshi

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Hirano Misato

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Inoue Tadashi

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Nakao Kazunari

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Shishido Yuji

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Nahayama Satoshi

Pfizer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge